Cart
sales@molnova.com
Pyropheophorbide-a
CAS No. 24533-72-0
Pyropheophorbide-a( Ppa )
Catalog No. M24128 CAS No. 24533-72-0
Pyropheophorbide-a is a promising photosensitizer for tumor photodynamic therapy (PDT).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | In Stock |
|
| 10MG | 72 | In Stock |
|
| 25MG | 160 | In Stock |
|
| 50MG | 267 | In Stock |
|
| 100MG | 395 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePyropheophorbide-a
-
NoteResearch use only, not for human use.
-
Brief DescriptionPyropheophorbide-a is a promising photosensitizer for tumor photodynamic therapy (PDT).
-
DescriptionPyropheophorbide-a is a promising photosensitizer for tumor photodynamic therapy (PDT).
-
In Vitro——
-
In Vivo——
-
SynonymsPpa
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number24533-72-0
-
Formula Weight534.65
-
Molecular FormulaC33H34N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:12.5 mg/mL (23.38 mM; Need ultrasonic)
-
SMILESCC1=C2C(N/C1=C\3)=C(CC2=O)C([C@H]4CCC(O)=O)=N/C([C@H]4C)=C\C5=C(C)C(C=C)=C(N5)/C=C6C(C)=C(CC)C3=N/6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li W, et al. cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic Therapy. Mol Pharm. 2018 Apr 2;15(4):1505-1514.
molnova catalog
related products
-
19-Oxocinobufotalin
19-Oxocinobufotalin 3-adipoylarginine ester shows significant inhibition effect against human hepatocellular carcinoma cell line SMMC-7721 in vitro.
-
2-Aminophenol
2-Aminophenol is used as a reagent for the synthesis of heterocyclic compounds and dyes.
-
RH01386
RH01386 is a small molecule that can prevent ER stress-induced β cell dysfunction and death, and inhibits proapoptotic gene expression,has the potential for type 2 diabetes treatment. RH01386 restores ER stress-impaired glucose-stimulated insulin secretion responses.
